
Cabot Corporation: stock overview
Price
$71.92
November 13, 2026Market cap $3.8B
What Ploutos Investor adds for Cabot
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
In short
Cabot had revenue of $3.6B over the last 12 months and net income of $190M, a net margin of 5.2%. Revenue grew by 7.3% a year on average over the last 5 years. At $71.92 the shares trade at a P/E of 20.3, against a median of 12.6 over the last 5 fiscal years. It has net debt of $1.0B. It pays a dividend yielding 2.57%.
From its SEC filings (latest fiscal year to September 30, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $3.8B
- 52.90M shares
- P/E
- 20.3
- Today20.3Median12.6
- Revenue, 12 months
- $3.6B
- +7.3% a year over 5 years
- Net margin
- 5.2%
- FY2025: 8.9%, above 74% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
-2.8% a year over 2 years
Fiscal years in figures
CBT's revenue, profit, cash flow and dividend with each year-end price, from FY2009 to FY2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $4.0B
- $3.8B
- Enterprise value
- $4.8B
- P/E 3-year median: 12.6
- 20.3
- EV / EBIT
- 9.8
- EV / Revenue
- 1.3
- P/B 3-year median: 3.0
- 2.4
- FCF yield 3-year median: 9.2%
- 7.4%
- Earnings yield 3-year median: 7.9%
- 4.9%
Profitability
- Gross margin
- 22.7%
- Operating margin
- 13.6%
- Net margin 3-year median: 9.5%
- 5.2%
- ROIC
- 14.4%
- ROIC, 5-year average
- 17.7%
- ROE
- 12.1%
Growth
- Revenue, yearly change
- -7.0%
- EPS, yearly change
- -10.4%
- FCF, yearly change
- -13.3%
- Revenue, average a year
- +7.3%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $250M
- Total debt
- $1.3B
- Net debt
- $1.0B
- Net debt / EBITDA
- 1.6x
- Interest cover
- 6.7x
- Current ratio
- 1.47
Balance sheet of June 30, 2026.
Returns to shareholders
- Dividend yield 3-year median: 2.2%
- 2.57%
- Buybacks
- 4.42%
- Total returned
- 6.99%
- Shares, yearly change
- -2.8%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 28).
Gross margin
25.3%
Above 26% of the 141 companies in its industry, and 30% of all.
Operating margin
16.7%
Above 81% of the 285 companies in its industry, and 78% of all.
Net margin
8.9%
Above 74% of the 302 companies in its industry, and 63% of all.
ROE
21.0%
Above 81% of the 267 companies in its industry, and 85% of all.
ROA
8.8%
Above 79% of the 313 companies in its industry, and 85% of all.
Revenue growth
-7.0%
Above 16% of the 292 companies in its industry, and 13% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- CABOT CORP
- CIK
- 16040
- Exchange
- NYSE
- Industry (SIC)
- 2890 · Miscellaneous Chemical Products
- Fiscal year ends
- September 30
- Latest annual report
- September 30, 2025
- Reporting currency
- USD
- Shares
- 52.90M
Other companies: Basic materials
The largest companies of the same sector, each with its own page.
- LINLinde+0,00%Compare with CBT
- NEMNewmont+0,00%Compare with CBT
- FCXFreeport-McMoRan+0,00%Compare with CBT
- SHWSherwin-Williams+0,00%Compare with CBT
- CRHCRH+0,00%Compare with CBT
- ECLEcolab+0,00%Compare with CBT
- APDAir Products and Chemicals+0,00%Compare with CBT
- CTVACorteva+0,00%Compare with CBT
The full analysis
What do Cabot's filings show?
These are Cabot's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is CBT's market cap?
Cabot Corporation's market cap is $3.8B, at a price of $71.92 on November 13, 2026 and 52.90M shares.
What is CBT's P/E?
CBT's P/E is 20.3, on earnings per share of $3.56 over the last 12 months. The median over the last 5 fiscal years was 12.6.
How much revenue does CBT have?
Cabot had revenue of $3.6B over the last 12 months. Over the last 5 years it changed by +7.3% a year on average.
Does CBT pay a dividend?
Yes. Cabot paid $1.85 per share over the last 12 months, a yield of 2.57% at today's price. All the figures are in the Dividend section.
Where do the figures come from?
From Cabot Corporation's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.